Selected research
Market Structure
Global Pharmacokinetic Research Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmacokinetic Research market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmacokinetic Research include Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences and Allucent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pharmacokinetic Research market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmacokinetic Research and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmacokinetic Research revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacokinetic Research market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmacokinetic Research Segment by Company
Eurofins
PPD
LabCorp
Charles River
BioPharma Services
Biotrial
QPS Holdings
Altasciences
Allucent
Admescope
CTI
WuXi AppTec
GenScript
Wuxi Biologics
Medicilon
Pharmaron
Frontage
Shanghai Model
Pharmacokinetic Research Segment by Type
In Vitro and Radioactive ADME
In Vivo PK and PD
New Drugs and New Molecules
Other
Pharmacokinetic Research Segment by Application
Pharmaceutical Industry
Government Agencies and Ministry of Health
Agriculture and Chemical Industry
University
Pharmacokinetic Research Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetic Research market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetic Research and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetic Research.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacokinetic Research in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacokinetic Research industry.
Chapter 3: Detailed analysis of Pharmacokinetic Research companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacokinetic Researchrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In Vitro and Radioactive ADME
- In Vivo PK and PD
- New Drugs and New Molecules
- Other
Applications
- Pharmaceutical Industry
- Government Agencies and Ministry of Health
- Agriculture and Chemical Industry
- University
Companies covered
- Eurofins
- PPD
- LabCorp
- Charles River
- BioPharma Services
- Biotrial
- QPS Holdings
- Altasciences
- Allucent
- Admescope
- CTI
- WuXi AppTec
- GenScript
- Wuxi Biologics
- Medicilon
- Pharmaron
- Frontage
- Shanghai Model
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmacokinetic Research Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 In Vitro and Radioactive ADME
- 1.2.3 In Vivo PK and PD
- 1.2.4 New Drugs and New Molecules
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharmacokinetic Research Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Industry
- 1.3.3 Government Agencies and Ministry of Health
- 1.3.4 Agriculture and Chemical Industry
- 1.3.5 University
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharmacokinetic Research Growth Trends by Region
- 1.5.1 Global Pharmacokinetic Research Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharmacokinetic Research Market Size by Region (2021-2026)
- 1.5.3 Pharmacokinetic Research Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharmacokinetic Research Market Dynamics
- 2.1 Pharmacokinetic Research Industry Trends
- 2.2 Pharmacokinetic Research Industry Drivers
- 2.3 Pharmacokinetic Research Industry Opportunities and Challenges
- 2.4 Pharmacokinetic Research Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharmacokinetic Research Revenue by Company (2021-2026)
- 3.2 Global Pharmacokinetic Research Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharmacokinetic Research Key Company Head office and Area Served
- 3.4 Global Pharmacokinetic Research Company, Product Type & Application
- 3.5 Global Pharmacokinetic Research Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharmacokinetic Research Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharmacokinetic Research Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharmacokinetic Research Tier 1, Tier 2, and Tier 3
4 Pharmacokinetic Research Market by Type
- 4.1 Global Pharmacokinetic Research Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharmacokinetic Research Market Size by Type (2021-2032)
- 4.3 Global Pharmacokinetic Research Market Size Share by Type (2021-2032)
5 Pharmacokinetic Research Market by Application
- 5.1 Global Pharmacokinetic Research Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharmacokinetic Research Market Size by Application (2021-2032)
- 5.3 Global Pharmacokinetic Research Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Eurofins
- 6.1.1 Eurofins Company Information
- 6.1.2 Eurofins Business Overview
- 6.1.3 Eurofins Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Eurofins Pharmacokinetic Research Product Portfolio
- 6.1.5 Eurofins Recent Developments
- 6.2 PPD
- 6.2.1 PPD Company Information
- 6.2.2 PPD Business Overview
- 6.2.3 PPD Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 PPD Pharmacokinetic Research Product Portfolio
- 6.2.5 PPD Recent Developments
- 6.3 LabCorp
- 6.3.1 LabCorp Company Information
- 6.3.2 LabCorp Business Overview
- 6.3.3 LabCorp Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 LabCorp Pharmacokinetic Research Product Portfolio
- 6.3.5 LabCorp Recent Developments
- 6.4 Charles River
- 6.4.1 Charles River Company Information
- 6.4.2 Charles River Business Overview
- 6.4.3 Charles River Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Charles River Pharmacokinetic Research Product Portfolio
- 6.4.5 Charles River Recent Developments
- 6.5 BioPharma Services
- 6.5.1 BioPharma Services Company Information
- 6.5.2 BioPharma Services Business Overview
- 6.5.3 BioPharma Services Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 BioPharma Services Pharmacokinetic Research Product Portfolio
- 6.5.5 BioPharma Services Recent Developments
- 6.6 Biotrial
- 6.6.1 Biotrial Company Information
- 6.6.2 Biotrial Business Overview
- 6.6.3 Biotrial Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Biotrial Pharmacokinetic Research Product Portfolio
- 6.6.5 Biotrial Recent Developments
- 6.7 QPS Holdings
- 6.7.1 QPS Holdings Company Information
- 6.7.2 QPS Holdings Business Overview
- 6.7.3 QPS Holdings Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 QPS Holdings Pharmacokinetic Research Product Portfolio
- 6.7.5 QPS Holdings Recent Developments
- 6.8 Altasciences
- 6.8.1 Altasciences Company Information
- 6.8.2 Altasciences Business Overview
- 6.8.3 Altasciences Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Altasciences Pharmacokinetic Research Product Portfolio
- 6.8.5 Altasciences Recent Developments
- 6.9 Allucent
- 6.9.1 Allucent Company Information
- 6.9.2 Allucent Business Overview
- 6.9.3 Allucent Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Allucent Pharmacokinetic Research Product Portfolio
- 6.9.5 Allucent Recent Developments
- 6.10 Admescope
- 6.10.1 Admescope Company Information
- 6.10.2 Admescope Business Overview
- 6.10.3 Admescope Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Admescope Pharmacokinetic Research Product Portfolio
- 6.10.5 Admescope Recent Developments
- 6.11 CTI
- 6.11.1 CTI Company Information
- 6.11.2 CTI Business Overview
- 6.11.3 CTI Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 CTI Pharmacokinetic Research Product Portfolio
- 6.11.5 CTI Recent Developments
- 6.12 WuXi AppTec
- 6.12.1 WuXi AppTec Company Information
- 6.12.2 WuXi AppTec Business Overview
- 6.12.3 WuXi AppTec Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 WuXi AppTec Pharmacokinetic Research Product Portfolio
- 6.12.5 WuXi AppTec Recent Developments
- 6.13 GenScript
- 6.13.1 GenScript Company Information
- 6.13.2 GenScript Business Overview
- 6.13.3 GenScript Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 GenScript Pharmacokinetic Research Product Portfolio
- 6.13.5 GenScript Recent Developments
- 6.14 Wuxi Biologics
- 6.14.1 Wuxi Biologics Company Information
- 6.14.2 Wuxi Biologics Business Overview
- 6.14.3 Wuxi Biologics Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Wuxi Biologics Pharmacokinetic Research Product Portfolio
- 6.14.5 Wuxi Biologics Recent Developments
- 6.15 Medicilon
- 6.15.1 Medicilon Company Information
- 6.15.2 Medicilon Business Overview
- 6.15.3 Medicilon Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Medicilon Pharmacokinetic Research Product Portfolio
- 6.15.5 Medicilon Recent Developments
- 6.16 Pharmaron
- 6.16.1 Pharmaron Company Information
- 6.16.2 Pharmaron Business Overview
- 6.16.3 Pharmaron Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Pharmaron Pharmacokinetic Research Product Portfolio
- 6.16.5 Pharmaron Recent Developments
- 6.17 Frontage
- 6.17.1 Frontage Company Information
- 6.17.2 Frontage Business Overview
- 6.17.3 Frontage Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Frontage Pharmacokinetic Research Product Portfolio
- 6.17.5 Frontage Recent Developments
- 6.18 Shanghai Model
- 6.18.1 Shanghai Model Company Information
- 6.18.2 Shanghai Model Business Overview
- 6.18.3 Shanghai Model Pharmacokinetic Research Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Shanghai Model Pharmacokinetic Research Product Portfolio
- 6.18.5 Shanghai Model Recent Developments
7 North America
- 7.1 North America Pharmacokinetic Research Market Size (2021-2032)
- 7.2 North America Pharmacokinetic Research Market Size by Type
- 7.2.1 North America Pharmacokinetic Research Market Size by Type (2021-2026)
- 7.2.2 North America Pharmacokinetic Research Market Size by Type (2027-2032)
- 7.2.3 North America Pharmacokinetic Research Market Share by Type (2021-2032)
- 7.3 North America Pharmacokinetic Research Market Size by Application
- 7.3.1 North America Pharmacokinetic Research Market Size by Application (2021-2026)
- 7.3.2 North America Pharmacokinetic Research Market Size by Application (2027-2032)
- 7.3.3 North America Pharmacokinetic Research Market Share by Application (2021-2032)
- 7.4 North America Pharmacokinetic Research Market Size by Country
- 7.4.1 North America Pharmacokinetic Research Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharmacokinetic Research Market Size by Country (2021-2026)
- 7.4.3 North America Pharmacokinetic Research Market Size by Country (2027-2032)
- 7.4.4 North America Pharmacokinetic Research Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharmacokinetic Research Market Size (2021-2032)
- 8.2 Europe Pharmacokinetic Research Market Size by Type
- 8.2.1 Europe Pharmacokinetic Research Market Size by Type (2021-2026)
- 8.2.2 Europe Pharmacokinetic Research Market Size by Type (2027-2032)
- 8.2.3 Europe Pharmacokinetic Research Market Share by Type (2021-2032)
- 8.3 Europe Pharmacokinetic Research Market Size by Application
- 8.3.1 Europe Pharmacokinetic Research Market Size by Application (2021-2026)
- 8.3.2 Europe Pharmacokinetic Research Market Size by Application (2027-2032)
- 8.3.3 Europe Pharmacokinetic Research Market Share by Application (2021-2032)
- 8.4 Europe Pharmacokinetic Research Market Size by Country
- 8.4.1 Europe Pharmacokinetic Research Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharmacokinetic Research Market Size by Country (2021-2026)
- 8.4.3 Europe Pharmacokinetic Research Market Size by Country (2027-2032)
- 8.4.4 Europe Pharmacokinetic Research Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharmacokinetic Research Market Size (2021-2032)
- 9.2 China Pharmacokinetic Research Market Size by Type
- 9.2.1 China Pharmacokinetic Research Market Size by Type (2021-2026)
- 9.2.2 China Pharmacokinetic Research Market Size by Type (2027-2032)
- 9.2.3 China Pharmacokinetic Research Market Share by Type (2021-2032)
- 9.3 China Pharmacokinetic Research Market Size by Application
- 9.3.1 China Pharmacokinetic Research Market Size by Application (2021-2026)
- 9.3.2 China Pharmacokinetic Research Market Size by Application (2027-2032)
- 9.3.3 China Pharmacokinetic Research Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharmacokinetic Research Market Size (2021-2032)
- 10.2 Asia Pharmacokinetic Research Market Size by Type
- 10.2.1 Asia Pharmacokinetic Research Market Size by Type (2021-2026)
- 10.2.2 Asia Pharmacokinetic Research Market Size by Type (2027-2032)
- 10.2.3 Asia Pharmacokinetic Research Market Share by Type (2021-2032)
- 10.3 Asia Pharmacokinetic Research Market Size by Application
- 10.3.1 Asia Pharmacokinetic Research Market Size by Application (2021-2026)
- 10.3.2 Asia Pharmacokinetic Research Market Size by Application (2027-2032)
- 10.3.3 Asia Pharmacokinetic Research Market Share by Application (2021-2032)
- 10.4 Asia Pharmacokinetic Research Market Size by Country
- 10.4.1 Asia Pharmacokinetic Research Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharmacokinetic Research Market Size by Country (2021-2026)
- 10.4.3 Asia Pharmacokinetic Research Market Size by Country (2027-2032)
- 10.4.4 Asia Pharmacokinetic Research Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharmacokinetic Research Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharmacokinetic Research Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharmacokinetic Research Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharmacokinetic Research Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharmacokinetic Research Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharmacokinetic Research Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharmacokinetic Research Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharmacokinetic Research Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharmacokinetic Research Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharmacokinetic Research Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharmacokinetic Research Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharmacokinetic Research Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharmacokinetic Research Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharmacokinetic Research Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst